Status:
UNKNOWN
Short-term, Long-term and Cost-effectiveness of Treating Depression and Anxiety Disorders in Children and Adolescents
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Collaborating Sponsors:
University of Bremen
Conditions:
Depression, Anxiety
Eligibility:
All Genders
8-16 years
Phase:
NA
Brief Summary
The current study will evaluate and compare the effectiveness of cognitive-behavioral and psychodynamic therapy. Therefore 420 children and adolescents (ages 8-16 years) with depression and/or anxiety...
Detailed Description
This study aims to optimize patient-centered care and to ensure scientific and legal approval of cognitive-behavioral and psychodynamic therapy for children and adolescents in the German health-care s...
Eligibility Criteria
Inclusion
- diagnosis of a depressive disorder (ICD-10; F30-F39) or an anxiety disorder (ICD-10; F40-F42)
- informed consent
- ages 8 to 16 years
Exclusion
- psychotic disorders, eating disorders, substance use related disorders (except caffeine and nicotine), autism spectrum disorders, mutism, personality disorders
- neurologic disorders
- severe mental retardation (filling out questionnaires and interview are not feasible)
- low command of the german language
Key Trial Info
Start Date :
December 22 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT03333239
Start Date
December 22 2017
End Date
August 1 2023
Last Update
December 21 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.